Skip to main content
OpenTrials

Clinical trial condition

Solid Tumor

Explore clinical trials studying Solid Tumor. Study availability and eligibility vary by location and protocol.

717 public trials 251 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumor trial results

Completed

Evaluation of IGM-7354 in Adults With Relapsed and/or Refractory Cancer

NCT05702424

Conditions
Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • Carolina Biooncology Institute Huntersville, North Carolina, United States
  • Oklahoma University Norman, Oklahoma, United States
View Trial Details
Completed

COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.

NCT04570839

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +19 more
Locations
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Johns Hopkins University Oncology Center. Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • START Midwest. Grand Rapids, Michigan, United States
View Trial Details
Completed

M6620 Plus Standard Treatment in Oesophageal and Other Cancer

NCT03641547

Conditions
Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +15 more
Locations
  • Velindre Cancer Centre Cardiff, United Kingdom
  • Beatson Cancer Centre Glasgow, United Kingdom
  • St James's University Hospital Leeds, United Kingdom
  • The Christie Manchester, United Kingdom
View Trial Details
Completed

Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma

NCT03934814

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • University of Alabama - Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Yale School of Medicine New Haven, Connecticut, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 21 locations
View Trial Details
Completed

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

NCT04641871

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Squamous Cell, +20 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View all 17 locations
View Trial Details

Related conditions